Experimental data demonstrated that PAQR5 promotes HCC cell proliferation, invasion, and EMT by activating the NF-κB signaling pathway, with regulatory effects on p65 phosphorylation and NF-κB activation mediated via the ERK pathway. Here, NFKB1 is linked to hepatocellular carcinoma.